Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Society of Nephrology : JASN"
DOI: 10.1681/asn.2016030278
Abstract: Sodium-glucose cotransporter 2 inhibition with canagliflozin decreases HbA1c, body weight, BP, and albuminuria, implying that canagliflozin confers renoprotection. We determined whether canagliflozin decreases albuminuria and reduces renal function decline independently of its glycemic effects in… read more here.
Keywords: function decline; canagliflozin 100; independently glycemic; renal function ... See more keywords